{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:42:27Z","timestamp":1792244547108,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Congenital pseudarthrosis of the tibia (CPT) remains one of the challenging conditions, with high rates of nonunion and refracture despite advances in surgical technique. Pharmacologic and biologic adjuncts have been introduced to enhance bone healing, but their role is incompletely defined. This scoping review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidance and a Population\u2013Concept\u2013Context framework. PubMed, Scopus, Embase, and Web of Science were searched till October 2025 for clinical studies using pharmacologic or biologic agents in CPT. Eligible designs included trials, cohorts, case series, and case reports reporting union-related outcomes. Thirteen studies published between 2006 and 2025 were included. Bone morphogenetic protein 2 (BMP-2) was evaluated in seven studies and BMP-7\/OP-1 in three; three of these studies also used bisphosphonates as co-therapy with BMP, while one investigated mesenchymal stromal cell transplantation. Sample sizes ranged from two to 39, with mean follow-up of approximately 2\u20137 years. Contemporary BMP-2-based cross-union protocols, often combined with bisphosphonates, have reported near-100% union within 3\u20139 months and markedly reduced refracture rates. Earlier BMP-7 series and single-agent BMP applications produced more modest and variable union rates, while the mesenchymal stem cell pilot demonstrated histologic repair without mechanical union. Complications were infrequent but long-term safety and growth-plate effects remain uncertain. Pharmacologic adjuncts, particularly BMP-2-based cross-union constructs combined with antiresorptive therapy, show promising structural outcomes in CPT. However, the supporting evidence is derived largely from small, specialized case series without robust comparative data, and should, therefore, be interpreted with caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bpb.0000000000001408","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:00:15Z","timestamp":1792242015000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Beyond surgery: a scoping review of pharmaceutical approaches in treating congenital pseudarthrosis of the tibia"],"prefix":"10.1097","author":[{"given":"Arkesh","family":"Madegowda","sequence":"first","affiliation":[{"name":"Department of Orthopedics, All India Institute of Medical Sciences, Raipur"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitanshu","family":"Barik","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, All India Institute of Medical Sciences, Nagpur"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, All India Institute of Medical Sciences, Guwahati"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Chacha Nehru Bal Chikitsalaya, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"R1-20261017","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis.","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"R2-20261017","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/JMDH.S362791","article-title":"Neurofibromatosis type 1: optimizing management with a multidisciplinary approach.","volume":"17","author":"Lalvani","year":"2024","journal-title":"J Multidiscip Healthc"},{"key":"R3-20261017","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4103\/0019-5413.104184","article-title":"Congenital pseudarthrosis of the tibia: management and complications.","volume":"46","author":"Shah","year":"2012","journal-title":"Indian J Orthop"},{"key":"R4-20261017","doi-asserted-by":"crossref","first-page":"e70021","DOI":"10.1002\/micr.70021","article-title":"Vascularized periosteal grafts for bone union in children: a systematic review.","volume":"45","author":"Soldado","year":"2025","journal-title":"Microsurgery"},{"key":"R5-20261017","doi-asserted-by":"crossref","first-page":"810880","DOI":"10.3389\/fbioe.2022.810880","article-title":"Application of BMP in bone tissue engineering.","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"R6-20261017","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/ma8041778","article-title":"Bone regeneration using bone morphogenetic proteins and various biomaterial carriers.","volume":"8","author":"Sheikh","year":"2015","journal-title":"Materials (Basel)"},{"key":"R7-20261017","first-page":"e66619","article-title":"Bone morphogenetic proteins: a promising approach for enhancing fracture healing.","volume":"16","author":"Nair","year":"2024","journal-title":"Cureus"},{"key":"R8-20261017","doi-asserted-by":"crossref","first-page":"115850","DOI":"10.1016\/j.bone.2021.115850","article-title":"Bisphosphonates impair the onset of bone formation at remodeling sites.","volume":"145","author":"Jensen","year":"2021","journal-title":"Bone"},{"key":"R9-20261017","doi-asserted-by":"crossref","first-page":"6940283","DOI":"10.1155\/2016\/6940283","article-title":"Stem cells applications in regenerative medicine and disease therapeutics.","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int J Cell Biol"},{"key":"R10-20261017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12891-024-08257-5","article-title":"Efficacy of the cross-union protocol in the treatment of congenital tibial pseudarthrosis: a comparative study.","volume":"26","author":"Jing","year":"2025","journal-title":"BMC Musculoskelet Disord"},{"key":"R11-20261017","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1097\/BPO.0000000000002138","article-title":"Combination treatment by cross-union of the tibia and fibula, autogenic iliac bone grafting, reliable fixation and bone morphogenetic proteins for the treatment of refractory congenital pseudarthrosis of the tibia.","volume":"42","author":"Wu","year":"2022","journal-title":"J Pediatr Orthop"},{"key":"R12-20261017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","article-title":"The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series.","volume":"92","author":"Richards","year":"2010","journal-title":"J Bone Jt Surg-Am"},{"key":"R13-20261017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/BPO.0000000000000789","article-title":"rhBMP-2 and intramedullary fixation in congenital pseudarthrosis of the tibia.","volume":"38","author":"Richards","year":"2018","journal-title":"J Pediatr Orthop"},{"key":"R14-20261017","first-page":"547","article-title":"Cross-union surgery for congenital pseudarthrosis of the tibia.","volume":"8","author":"Shannon","year":"2021","journal-title":"Children (Basel)"},{"key":"R15-20261017","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2106\/00004623-200603000-00023","article-title":"Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7): a report of five cases.","volume":"88","author":"Lee","year":"2006","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20261017","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1007\/s11999-009-0967-7","article-title":"Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience.","volume":"467","author":"Dohin","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"R17-20261017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11832-012-0421-3","article-title":"Masquelet\u2019s procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis.","volume":"6","author":"Dohin","year":"2012","journal-title":"J Child Orthop"},{"key":"R18-20261017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10856-017-5868-9","article-title":"Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: a retrospective study with a minimum 2-year follow-up.","volume":"28","author":"Hissnauer","year":"2017","journal-title":"J Mater Sci Mater Med"},{"key":"R19-20261017","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1302\/0301-620X.93B5.25938","article-title":"Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series.","volume":"93","author":"Spiro","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"R20-20261017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11832-010-0293-3","article-title":"Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.","volume":"4","author":"Birke","year":"2010","journal-title":"J Child Orthop"},{"key":"R21-20261017","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00264-014-2361-7","article-title":"Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial.","volume":"38","author":"Das","year":"2014","journal-title":"Int Orthop"},{"key":"R22-20261017","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/14653249.2010.487898","article-title":"Attempt to treat congenital pseudarthrosis of the tibia with mesenchymal stromal cell transplantation.","volume":"12","author":"Tikkanen","year":"2010","journal-title":"Cytotherapy"},{"key":"R23-20261017","doi-asserted-by":"crossref","first-page":"1000575","DOI":"10.3389\/fcell.2022.1000575","article-title":"Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model.","volume":"10","author":"Nandi","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R25-20261017","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fcell.2019.00268","article-title":"Adult stem cells for bone regeneration and repair.","volume":"7","author":"Iaquinta","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R26-20261017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13287-020-02001-1","article-title":"Mesenchymal stem cells: amazing remedies for bone and cartilage defects.","volume":"11","author":"Kangari","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"R27-20261017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13023-019-1196-0","article-title":"Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.","volume":"14","author":"Zhu","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R28-20261017","doi-asserted-by":"crossref","first-page":"20010","DOI":"10.1038\/srep20010","article-title":"Capturing the wide variety of impaired fracture healing phenotypes in neurofibromatosis type 1 with eight key factors: a computational study.","volume":"7","author":"Carlier","year":"2016","journal-title":"Sci Rep"},{"key":"R29-20261017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11832-012-0477-0","article-title":"Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.","volume":"7","author":"Horn","year":"2013","journal-title":"J Child Orthop"},{"key":"R30-20261017","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/SCS.0b013e318256657c","article-title":"Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population.","volume":"24","author":"Beidas","year":"2013","journal-title":"J Craniofac Surg"},{"key":"R31-20261017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/ijpvm.IJPVM_33_19","article-title":"Therapeutic dimensions of bisphosphonates: a clinical update.","volume":"11","author":"Vannala","year":"2020","journal-title":"Int J Prev Med"},{"key":"R32-20261017","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth.","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R33-20261017","doi-asserted-by":"crossref","first-page":"e1049","DOI":"10.3928\/01477447-20141124-50","article-title":"BMP-7 versus BMP-2 for the treatment of long bone nonunion.","volume":"37","author":"Conway","year":"2014","journal-title":"Orthopedics"},{"key":"R34-20261017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00003086-199505000-00007","article-title":"Congenital pseudarthrosis of the tibia. Long-term followup of 29 cases treated by microvascular bone transfer.","volume":"314","author":"Gilbert","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"R35-20261017","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.otsr.2011.09.001","article-title":"Congenital pseudarthrosis of the tibia.","volume":"97","author":"Pannier","year":"2011","journal-title":"Orthop Traumatol Surg Res"}],"container-title":["Journal of Pediatric Orthopaedics B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BPB.0000000000001408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:00:19Z","timestamp":1792242019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BPB.0000000000001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1097\/bpb.0000000000001408","relation":{},"ISSN":["1060-152X","1473-5865"],"issn-type":[{"value":"1060-152X","type":"print"},{"value":"1473-5865","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2026-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}